Skip to Main content Skip to Navigation
Journal articles

Should we introduce early a new biological agent in patients with Inflammatory Bowel Disease after anti-TNF discontinuation due to severe anti-TNF-induced skin lesions? A multicenter cohort study

Document type :
Journal articles
Complete list of metadata

https://hal.archives-ouvertes.fr/hal-03687586
Contributor : Laurent Jonchère Connect in order to contact the contributor
Submitted on : Friday, June 3, 2022 - 2:11:09 PM
Last modification on : Tuesday, June 28, 2022 - 1:50:21 PM

Links full text

Identifiers

Citation

C. Cottron, X. Treton, R. Altwegg, C. Reenaers, A. Amiot, et al.. Should we introduce early a new biological agent in patients with Inflammatory Bowel Disease after anti-TNF discontinuation due to severe anti-TNF-induced skin lesions? A multicenter cohort study. Journal of Crohn's and Colitis, Elsevier - Oxford University Press, 2022, 16, pp.I502-I502. ⟨10.1093/ecco-jcc/jjab232.684⟩. ⟨hal-03687586⟩

Share

Metrics

Record views

7